Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 168

1.

ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancreatic cancer.

Kuninty PR, Bansal R, De Geus SWL, Mardhian DF, Schnittert J, van Baarlen J, Storm G, Bijlsma MF, van Laarhoven HW, Metselaar JM, Kuppen PJK, Vahrmeijer AL, Östman A, Sier CFM, Prakash J.

Sci Adv. 2019 Sep 4;5(9):eaax2770. doi: 10.1126/sciadv.aax2770. eCollection 2019 Sep.

PMID:
31517053
2.

Quantitative margin assessment of radiofrequency ablation of a solitary colorectal hepatic metastasis using MIRADA RTx on CT scans: a feasibility study.

Sibinga Mulder BG, Hendriks P, Baetens TR, van Erkel AR, van Rijswijk CSP, van der Meer RW, van de Velde CJH, Vahrmeijer AL, Mieog JSD, Burgmans MC.

BMC Med Imaging. 2019 Aug 20;19(1):71. doi: 10.1186/s12880-019-0360-2.

3.

Intraoperative detection of the remnant cystic duct during robot-assisted surgery using near-infrared fluorescence imaging: a case report.

van Manen L, Tummers QRJG, Inderson A, Bhalla A, Vahrmeijer AL, Bonsing BA, Mieog JSD.

BMC Surg. 2019 Aug 7;19(1):104. doi: 10.1186/s12893-019-0567-8.

4.

A zwitterionic near-infrared fluorophore for real-time ureter identification during laparoscopic abdominopelvic surgery.

de Valk KS, Handgraaf HJ, Deken MM, Sibinga Mulder BG, Valentijn AR, Terwisscha van Scheltinga AG, Kuil J, van Esdonk MJ, Vuijk J, Bevers RF, Peeters KC, Holman FA, Frangioni JV, Burggraaf J, Vahrmeijer AL.

Nat Commun. 2019 Jul 16;10(1):3118. doi: 10.1038/s41467-019-11014-1.

5.

Latest developments in molecular tracers for fluorescence image-guided cancer surgery.

Hernot S, van Manen L, Debie P, Mieog JSD, Vahrmeijer AL.

Lancet Oncol. 2019 Jul;20(7):e354-e367. doi: 10.1016/S1470-2045(19)30317-1. Review.

PMID:
31267970
6.

A systematic review of the use of near-infrared fluorescence imaging in patients with peripheral artery disease.

van den Hoven P, Ooms S, van Manen L, van der Bogt KEA, van Schaik J, Hamming JF, Vahrmeijer AL, van der Vorst JR, Mieog JSD.

J Vasc Surg. 2019 Jul;70(1):286-297.e1. doi: 10.1016/j.jvs.2018.11.023. Review.

PMID:
31230648
7.

Yield of staging laparoscopy before treatment of locally advanced pancreatic cancer to detect occult metastases.

Suker M, Koerkamp BG, Coene PP, van der Harst E, Bonsing BA, Vahrmeijer AL, Mieog JSD, Swijnenburg RJ, Dwarkasing RS, Roos D, van Eijck CHJ.

Eur J Surg Oncol. 2019 Jun 3. pii: S0748-7983(19)30495-0. doi: 10.1016/j.ejso.2019.06.004. [Epub ahead of print]

PMID:
31186205
8.

A Prospective Clinical Trial to Determine the Effect of Intraoperative Ultrasound on Surgical Strategy and Resection Outcome in Patients with Pancreatic Cancer.

Sibinga Mulder BG, Feshtali S, Fariña Sarasqueta A, Vahrmeijer AL, Swijnenburg RJ, Bonsing BA, Mieog JSD.

Ultrasound Med Biol. 2019 Aug;45(8):2019-2026. doi: 10.1016/j.ultrasmedbio.2019.04.020. Epub 2019 May 24.

PMID:
31130412
9.

A method for semi-automated image analysis of HLA class I tumour epithelium expression in rectal cancer.

Krijgsman D, Van Vlierberghe RLP, Evangelou V, Vahrmeijer AL, Van de Velde CJH, Sier CFM, Kuppen PJK.

Eur J Histochem. 2019 May 20;63(2). doi: 10.4081/ejh.2019.3028.

10.

Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile.

Krijgsman D, de Vries NL, Skovbo A, Andersen MN, Swets M, Bastiaannet E, Vahrmeijer AL, van de Velde CJH, Heemskerk MHM, Hokland M, Kuppen PJK.

Cancer Immunol Immunother. 2019 Jun;68(6):1011-1024. doi: 10.1007/s00262-019-02343-7. Epub 2019 May 3.

11.

Impact of resection margin status on recurrence and survival in pancreatic cancer surgery.

Tummers WS, Groen JV, Sibinga Mulder BG, Farina-Sarasqueta A, Morreau J, Putter H, van de Velde CJ, Vahrmeijer AL, Bonsing BA, Mieog JS, Swijnenburg RJ.

Br J Surg. 2019 Jul;106(8):1055-1065. doi: 10.1002/bjs.11115. Epub 2019 Mar 18.

12.

Fluorescence-guided tumor detection with a novel anti-EpCAM targeted antibody fragment: Preclinical validation.

Boogerd LSF, Boonstra MC, Prevoo HAJM, Handgraaf HJM, Kuppen PJK, van de Velde CJH, Fish A, Cordfunke RA, Valentijn ARPM, Terwisscha van Scheltinga AG, MacDonald GC, Cizeau J, Premsukh A, Vinkenburg van Slooten ML, Burggraaf J, Sier CFM, Vahrmeijer AL.

Surg Oncol. 2019 Mar;28:1-8. doi: 10.1016/j.suronc.2018.10.004. Epub 2018 Oct 23.

PMID:
30851880
13.

Epidural and Non-epidural Analgesia in Patients Undergoing Open Pancreatectomy: a Retrospective Cohort Study.

Groen JV, Slotboom DEF, Vuyk J, Martini CH, Dahan A, Vahrmeijer AL, Bonsing BA, Mieog JSD.

J Gastrointest Surg. 2019 Feb 26. doi: 10.1007/s11605-019-04136-w. [Epub ahead of print]

PMID:
30809780
14.

Outcomes following pancreatic surgery using three different thromboprophylaxis regimens.

Hanna-Sawires RG, Groen JV, Klok FA, Tollenaar RAEM, Mesker WE, Swijnenburg RJ, Vahrmeijer AL, Bonsing BA, Mieog JSD.

Br J Surg. 2019 May;106(6):765-773. doi: 10.1002/bjs.11103. Epub 2019 Feb 18.

15.

Safety of Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Liver Metastases from Ocular Melanoma Using the Delcath Systems' Second-Generation Hemofiltration System: A Prospective Non-randomized Phase II Trial.

Meijer TS, Burgmans MC, Fiocco M, de Geus-Oei LF, Kapiteijn E, de Leede EM, Martini CH, van der Meer RW, Tijl FGJ, Vahrmeijer AL.

Cardiovasc Intervent Radiol. 2019 Jun;42(6):841-852. doi: 10.1007/s00270-019-02177-x. Epub 2019 Feb 14.

16.

Detection of visually occult metastatic lymph nodes using molecularly targeted fluorescent imaging during surgical resection of pancreatic cancer.

Tummers WS, Miller SE, Teraphongphom NT, van den Berg NS, Hasan A, Longacre TA, Fisher GA, Bonsing BA, Vahrmeijer AL, Gambhir SS, Swijnenburg RJ, Rosenthal EL, Poultsides GA.

HPB (Oxford). 2019 Jul;21(7):883-890. doi: 10.1016/j.hpb.2018.11.008. Epub 2019 Feb 2.

PMID:
30723062
17.

Recommendations for reporting on emerging optical imaging agents to promote clinical approval.

Tummers WS, Warram JM, van den Berg NS, Miller SE, Swijnenburg RJ, Vahrmeijer AL, Rosenthal EL.

Theranostics. 2018 Oct 22;8(19):5336-5347. doi: 10.7150/thno.27384. eCollection 2018. Review.

18.

Response to the Letter to the Editor.

Vuijk FA, Hilling DE, Mieog JSD, Vahrmeijer AL.

J Surg Oncol. 2019 Mar;119(3):399. doi: 10.1002/jso.25310. Epub 2018 Dec 3. No abstract available.

PMID:
30508288
19.

A dual-labeled cRGD-based PET/optical tracer for pre-operative staging and intraoperative treatment of colorectal cancer.

Sibinga Mulder BG, Handgraaf HJ, Vugts DJ, Sewing C, Windhorst AD, Stammes M, de Geus-Oei LF, Bordo MW, Mieog JSD, van de Velde CJ, Frangioni JV, Vahrmeijer AL.

Am J Nucl Med Mol Imaging. 2018 Oct 20;8(5):282-291. eCollection 2018.

20.

Gadoxetic acid-enhanced magnetic resonance imaging significantly influences the clinical course in patients with colorectal liver metastases.

Sibinga Mulder BG, Visser K, Feshtali S, Vahrmeijer AL, Swijnenburg RJ, Hartgrink HH, van den Boom R, Burgmans MC, Mieog JSD.

BMC Med Imaging. 2018 Nov 15;18(1):44. doi: 10.1186/s12880-018-0289-x.

21.

Correction to: ASO Author Reflections: Fluorescent-Guided Surgery to Augment Pancreatic Cancer Surgery.

Tummers WS, Rosenthal EL, Vahrmeijer AL, Poultsides GA.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):999. doi: 10.1245/s10434-018-7065-6.

PMID:
30426262
22.

Staging laparoscopy with ultrasound and near-infrared fluorescence imaging to detect occult metastases of pancreatic and periampullary cancer.

Handgraaf HJM, Sibinga Mulder BG, Shahbazi Feshtali S, Boogerd LSF, van der Valk MJM, Fariña Sarasqueta A, Swijnenburg RJ, Bonsing BA, Vahrmeijer AL, Mieog JSD.

PLoS One. 2018 Nov 1;13(11):e0205960. doi: 10.1371/journal.pone.0205960. eCollection 2018.

23.

ASO Author Reflections: Fluorescent-Guided Surgery to Augment Pancreatic Cancer Surgery.

Tummers WS, Rosenthal EL, Vahrmeijer AL, Poultsides GA.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):820-821. doi: 10.1245/s10434-018-6904-9. Epub 2018 Oct 12. No abstract available. Erratum in: Ann Surg Oncol. 2018 Nov 13;:.

PMID:
30315384
24.

Fluorescent-guided surgery for sentinel lymph node detection in gastric cancer and carcinoembryonic antigen targeted fluorescent-guided surgery in colorectal and pancreatic cancer.

Vuijk FA, Hilling DE, Mieog JSD, Vahrmeijer AL.

J Surg Oncol. 2018 Aug;118(2):315-323. doi: 10.1002/jso.25139. Epub 2018 Sep 14. Review.

25.

Image-Guided Surgery in Patients with Pancreatic Cancer: First Results of a Clinical Trial Using SGM-101, a Novel Carcinoembryonic Antigen-Targeting, Near-Infrared Fluorescent Agent.

Hoogstins CES, Boogerd LSF, Sibinga Mulder BG, Mieog JSD, Swijnenburg RJ, van de Velde CJH, Farina Sarasqueta A, Bonsing BA, Framery B, Pèlegrin A, Gutowski M, Cailler F, Burggraaf J, Vahrmeijer AL.

Ann Surg Oncol. 2018 Oct;25(11):3350-3357. doi: 10.1245/s10434-018-6655-7. Epub 2018 Jul 26.

26.

[Intraoperative imaging using fluorescence, 5 years later].

van der Valk MJM, Handgraaf HJM, Sibinga-Mulder BG, Hilling DE, van Dam GM, Vahrmeijer AL.

Ned Tijdschr Geneeskd. 2018 Jun 21;162. pii: D2067. Dutch.

PMID:
30040255
27.

A practical guide for the use of indocyanine green and methylene blue in fluorescence-guided abdominal surgery.

van Manen L, Handgraaf HJM, Diana M, Dijkstra J, Ishizawa T, Vahrmeijer AL, Mieog JSD.

J Surg Oncol. 2018 Aug;118(2):283-300. doi: 10.1002/jso.25105. Epub 2018 Jun 24. Review.

28.

The clinical usefulness of optical coherence tomography during cancer interventions.

van Manen L, Dijkstra J, Boccara C, Benoit E, Vahrmeijer AL, Gora MJ, Mieog JSD.

J Cancer Res Clin Oncol. 2018 Oct;144(10):1967-1990. doi: 10.1007/s00432-018-2690-9. Epub 2018 Jun 20.

29.

Advances in Diagnostic and Intraoperative Molecular Imaging of Pancreatic Cancer.

Tummers WS, Willmann JK, Bonsing BA, Vahrmeijer AL, Gambhir SS, Swijnenburg RJ.

Pancreas. 2018 Jul;47(6):675-689. doi: 10.1097/MPA.0000000000001075. Review.

30.

Intraoperative Pancreatic Cancer Detection using Tumor-Specific Multimodality Molecular Imaging.

Tummers WS, Miller SE, Teraphongphom NT, Gomez A, Steinberg I, Huland DM, Hong S, Kothapalli SR, Hasan A, Ertsey R, Bonsing BA, Vahrmeijer AL, Swijnenburg RJ, Longacre TA, Fisher GA, Gambhir SS, Poultsides GA, Rosenthal EL.

Ann Surg Oncol. 2018 Jul;25(7):1880-1888. doi: 10.1245/s10434-018-6453-2. Epub 2018 Apr 17.

31.

Biomarker expression in rectal cancer tissue before and after neoadjuvant therapy.

Boogerd LS, van der Valk MJ, Boonstra MC, Prevoo HA, Hilling DE, van de Velde CJ, Sier CF, Fariña Sarasqueta A, Vahrmeijer AL.

Onco Targets Ther. 2018 Mar 23;11:1655-1664. doi: 10.2147/OTT.S145473. eCollection 2018.

32.

Variation in hospital mortality after pancreatoduodenectomy is related to failure to rescue rather than major complications: a nationwide audit.

van Rijssen LB, Zwart MJ, van Dieren S, de Rooij T, Bonsing BA, Bosscha K, van Dam RM, van Eijck CH, Gerhards MF, Gerritsen JJ, van der Harst E, de Hingh IH, de Jong KP, Kazemier G, Klaase J, van der Kolk BM, van Laarhoven CJ, Luyer MD, Molenaar IQ, Patijn GA, Rupert CG, Scheepers JJ, van der Schelling GP, Vahrmeijer AL, Busch ORC, van Santvoort HC, Groot Koerkamp B, Besselink MG; Dutch Pancreatic Cancer Group.

HPB (Oxford). 2018 Aug;20(8):759-767. doi: 10.1016/j.hpb.2018.02.640. Epub 2018 Mar 21.

33.

Detecting tumour-positive resection margins after oral cancer surgery by spraying a fluorescent tracer activated by gamma-glutamyltranspeptidase.

Slooter MD, Handgraaf HJM, Boonstra MC, van der Velden LA, Bhairosingh SS, Que I, de Haan LM, Keereweer S, van Driel PBAA, Chan A, Kobayashi H, Vahrmeijer AL, Löwik CWGM.

Oral Oncol. 2018 Mar;78:1-7. doi: 10.1016/j.oraloncology.2017.12.006. Epub 2018 Jan 9.

34.

Neoadjuvant therapy affects margins and margins affect all: perioperative and survival outcomes in resected pancreatic adenocarcinoma.

de Geus SWL, Kasumova GG, Sachs TE, Ng SC, Kent TS, Moser AJ, Vahrmeijer AL, Callery MP, Tseng JF.

HPB (Oxford). 2018 Jun;20(6):573-581. doi: 10.1016/j.hpb.2017.12.004. Epub 2018 Feb 6.

35.

Folate receptor-α targeted near-infrared fluorescence imaging in high-risk endometrial cancer patients: a tissue microarray and clinical feasibility study.

Boogerd LSF, Hoogstins CES, Gaarenstroom KN, de Kroon CD, Beltman JJ, Bosse T, Stelloo E, Vuyk J, Low PS, Burggraaf J, Vahrmeijer AL.

Oncotarget. 2017 Dec 11;9(1):791-801. doi: 10.18632/oncotarget.23155. eCollection 2018 Jan 2.

36.

Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study.

Boogerd LSF, Hoogstins CES, Schaap DP, Kusters M, Handgraaf HJM, van der Valk MJM, Hilling DE, Holman FA, Peeters KCMJ, Mieog JSD, van de Velde CJH, Farina-Sarasqueta A, van Lijnschoten I, Framery B, Pèlegrin A, Gutowski M, Nienhuijs SW, de Hingh IHJT, Nieuwenhuijzen GAP, Rutten HJT, Cailler F, Burggraaf J, Vahrmeijer AL.

Lancet Gastroenterol Hepatol. 2018 Mar;3(3):181-191. doi: 10.1016/S2468-1253(17)30395-3. Epub 2018 Jan 30.

PMID:
29361435
37.

Modalities for image- and molecular-guided cancer surgery.

Stammes MA, Bugby SL, Porta T, Pierzchalski K, Devling T, Otto C, Dijkstra J, Vahrmeijer AL, de Geus-Oei LF, Mieog JSD.

Br J Surg. 2018 Jan;105(2):e69-e83. doi: 10.1002/bjs.10789. Review.

PMID:
29341161
38.

Development and Preclinical Validation of a Cysteine Knottin Peptide Targeting Integrin αvβ6 for Near-infrared Fluorescent-guided Surgery in Pancreatic Cancer.

Tummers WS, Kimura RH, Abou-Elkacem L, Beinat C, Vahrmeijer AL, Swijnenburg RJ, Willmann JK, Gambhir SS.

Clin Cancer Res. 2018 Apr 1;24(7):1667-1676. doi: 10.1158/1078-0432.CCR-17-2491. Epub 2018 Jan 3.

39.

Fluorescence- and multispectral optoacoustic imaging for an optimized detection of deeply located tumors in an orthotopic mouse model of pancreatic carcinoma.

Napp J, Stammes MA, Claussen J, Prevoo HAJM, Sier CFM, Hoeben FJM, Robillard MS, Vahrmeijer AL, Devling T, Chan AB, de Geus-Oei LF, Alves F.

Int J Cancer. 2018 May 15;142(10):2118-2129. doi: 10.1002/ijc.31236. Epub 2018 Jan 19.

40.

Is Neoadjuvant Therapy Sufficient in Resected Pancreatic Cancer Patients? A National Study.

de Geus SWL, Kasumova GG, Eskander MF, Ng SC, Kent TS, James Moser A, Vahrmeijer AL, Callery MP, Tseng JF.

J Gastrointest Surg. 2018 Feb;22(2):214-225. doi: 10.1007/s11605-017-3541-8. Epub 2017 Oct 4.

PMID:
29235000
41.

Intraoperative Near-Infrared Fluorescence Imaging of Multiple Pancreatic Neuroendocrine Tumors: A Case Report.

Handgraaf HJM, Boogerd LSF, Shahbazi Feshtali S, Fariña Sarasqueta A, Snel M, Swijnenburg RJ, Vahrmeijer AL, Bonsing BA, Mieog JSD.

Pancreas. 2018 Jan;47(1):130-133. doi: 10.1097/MPA.0000000000000951.

PMID:
29232342
42.

Future applications of fusion-fluorescence imaging during laparoscopic procedures.

Sibinga Mulder BG, Vahrmeijer AL, Mieog JSD.

Transl Gastroenterol Hepatol. 2017 Sep 21;2:76. doi: 10.21037/tgh.2017.09.03. eCollection 2017. No abstract available.

43.

Local delivery of liposomal prednisolone leads to an anti-inflammatory profile in renal ischaemia-reperfusion injury in the rat.

van Alem CMA, Boonstra M, Prins J, Bezhaeva T, van Essen MF, Ruben JM, Vahrmeijer AL, van der Veer EP, de Fijter JW, Reinders ME, Meijer O, Metselaar JM, van Kooten C, Rotmans JI.

Nephrol Dial Transplant. 2018 Jan 1;33(1):44-53. doi: 10.1093/ndt/gfx204.

PMID:
28992069
44.

Selection of optimal molecular targets for tumor-specific imaging in pancreatic ductal adenocarcinoma.

Tummers WS, Farina-Sarasqueta A, Boonstra MC, Prevoo HA, Sier CF, Mieog JS, Morreau J, van Eijck CH, Kuppen PJ, van de Velde CJ, Bonsing BA, Vahrmeijer AL, Swijnenburg RJ.

Oncotarget. 2017 May 26;8(34):56816-56828. doi: 10.18632/oncotarget.18232. eCollection 2017 Aug 22.

45.

In Search for Optimal Targets for Intraoperative Fluorescence Imaging of Peritoneal Metastasis From Colorectal Cancer.

Hoogstins CE, Weixler B, Boogerd LS, Hoppener DJ, Prevoo HA, Sier CF, Burger JW, Verhoef C, Bhairosingh S, Farina Sarasqueta A, Burggraaf J, Vahrmeijer AL.

Biomark Cancer. 2017 Aug 28;9:1179299X17728254. doi: 10.1177/1179299X17728254. eCollection 2017.

46.

Erratum to: Prospective Clinical and Pharmacological Evaluation of the Delcath System's Second-Generation (GEN2) Hemofiltration System in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan.

de Leede EM, Burgmans MC, Meijer TS, Martini CH, Tijl FGJ, Vuyk J, van Erkel AR, van der Velde CJH, Kapiteijn E, Vahrmeijer AL.

Cardiovasc Intervent Radiol. 2017 Dec;40(12):1966. doi: 10.1007/s00270-017-1766-2. No abstract available.

47.

Diagnostic value of targeted next-generation sequencing in patients with suspected pancreatic or periampullary cancer.

Sibinga Mulder BG, Mieog JSD, Farina Sarasqueta A, Handgraaf HJ, Vasen HFA, Swijnenburg RJ, Luelmo SAC, Feshtali S, Inderson A, Vahrmeijer AL, Bonsing BA, Wezel TV, Morreau H.

J Clin Pathol. 2018 Mar;71(3):246-252. doi: 10.1136/jclinpath-2017-204607. Epub 2017 Aug 3.

PMID:
28775172
48.

Prognostic Impact of Urokinase Plasminogen Activator Receptor Expression in Pancreatic Cancer: Malignant Versus Stromal Cells.

de Geus SW, Baart VM, Boonstra MC, Kuppen PJ, Prevoo HA, Mazar AP, Bonsing BA, Morreau H, van de Velde CJ, Vahrmeijer AL, Sier CF.

Biomark Insights. 2017 Jun 22;12:1177271917715443. doi: 10.1177/1177271917715443. eCollection 2017. Review.

49.

Correlation Between Preoperative Serum Carcinoembryonic Antigen Levels and Expression on Pancreatic and Rectal Cancer Tissue.

Boogerd LSF, Vuijk FA, Hoogstins CES, Handgraaf HJM, van der Valk MJM, Kuppen PJK, Sier CFM, van de Velde CJH, Burggraaf J, Fariña-Sarasqueta A, Vahrmeijer AL.

Biomark Cancer. 2017 May 17;9:1179299X17710016. doi: 10.1177/1179299X17710016. eCollection 2017.

50.

SGM-101: An innovative near-infrared dye-antibody conjugate that targets CEA for fluorescence-guided surgery.

Gutowski M, Framery B, Boonstra MC, Garambois V, Quenet F, Dumas K, Scherninski F, Cailler F, Vahrmeijer AL, Pèlegrin A.

Surg Oncol. 2017 Jun;26(2):153-162. doi: 10.1016/j.suronc.2017.03.002. Epub 2017 Mar 9.

Supplemental Content

Loading ...
Support Center